Blackstone Group »

Nektar Therapeutics shares owned by Blackstone Group

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Blackstone Group from 13F filings

Historical chart of Blackstone Group investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Blackstone Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Blackstone Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.0M 29k 69.81

More positions owned by Blackstone Group

Cheniere Energy Partners Com Unit (CQP)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Digital Realty Trust (DLR)
Corebridge Finl (CRBG)
Legence Corp Cl A (LGN)
FirstEnergy (FE)
Williams Companies (WMB)
Targa Res Corp (TRGP)
Enterprise Products Partners (EPD)
Kinder Morgan (KMI)
Enbridge (ENB)
MPLX Com Unit Rep Ltd (MPLX)
Energy Transfer Com Ut Ltd Ptn (ET)
Kinetik Holdings Com New Cl A (KNTK)

View all positions for Blackstone Group

Top funds holding Nektar Therapeutics

FMR
Two Seas Capital
BlackRock
BVF
Susquehanna International
Vanguard Capital Management
Two Sigma Investments
Vestal Point Capital
Geode Capital Management
Prosight Management
Armistice Capital
Morgan Stanley
Millennium Management
Gilder, Gagnon, Howe & Co
Citadel Advisors

View all funds holding Nektar Therapeutics